Global Custom Market Research Reports Provider Company

phone

BioMarin Pharmaceutical Inc (BMRN) - Financial and Strategic SWOT Analysis Review

  • Published Date: 11 Apr 2018
  • Number of Pages: 62
  • Category: Pharmaceuticals
  • Country: United States of America
BioMarin Pharmaceutical Inc (BMRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

BioMarin Pharmaceutical Inc (BioMarin) is a biopharmaceutical company which develops and commercializes innovative pharmaceuticals for treatment of serious diseases and medical conditions such as Kyndrisa (drisapersen), Duchenne muscular dystrophy (DMD), phenylketonuria (PKU), achondroplasia, late infantile neuronal ceroid lipofuscinosis (CLN2) and hemophilia A. Its product portfolio consists of products and multiple clinical and preclinical product candidates. The company operates through its manufacturing facilities in Novato, California and has its presence in US, Europe, Latin America, the Middle East, and Asia-Pacific. BioMarin is headquartered in San Rafael, California, the US.

BioMarin Pharmaceutical Inc Key Recent Developments

Feb 22,2018: BioMarin Reports Fourth Quarter 2017 Financial Results
Feb 05,2018: BioMarin Announces 20 Presentations at 14th Annual WORLDSymposium 2018
Dec 14,2017: Gene therapy success could lead to cure for haemophilia
Dec 09,2017: New Therapies Improve Outlook for Bleeding and Clotting Disorders
Oct 26,2017: BioMarin Announces Third Quarter 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Publisher Name : GlobalData

3
List of Tables 5
List of Figures 5
Section 1 - About the Company 6
BioMarin Pharmaceutical Inc - Key Facts 6
BioMarin Pharmaceutical Inc - Key Employees 7
BioMarin Pharmaceutical Inc - Key Employee Biographies 8
BioMarin Pharmaceutical Inc - Major Products and Services 9
BioMarin Pharmaceutical Inc - History 10
BioMarin Pharmaceutical Inc - Company Statement 15
BioMarin Pharmaceutical Inc - Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Joint Venture 18
Section 2 Company Analysis 19
Company Overview 19
BioMarin Pharmaceutical Inc - Business Description 19
Product Category: Aldurazyme (laronidase) 19
Overview 19
Performance 19
Product Category: Brineura (cerliponase alfa) 19
Overview 19
Performance 19
Product Category: Firdapse 19
Overview 19
Performance 19
Product Category: Kuvan (sapropterin hydrochloride) 20
Overview 20
Performance 20
Product Category: Naglazyme (galsulfase) 20
Overview 20
Performance 20
Product Category: Vimizim (elosulfase alfa) 20
Overview 20
Performance 20
Geographical Segment: Europe 20
Performance 20
Geographical Segment: Latin America 20
Performance 20
Geographical Segment: Rest of the World 21
Performance 21
Geographical Segment: United States 21
Performance 21
BioMarin Pharmaceutical Inc - Corporate Strategy 22
BioMarin Pharmaceutical Inc - SWOT Analysis 23
SWOT Analysis - Overview 23
BioMarin Pharmaceutical Inc - Strengths 23
BioMarin Pharmaceutical Inc - Weaknesses 24
BioMarin Pharmaceutical Inc - Opportunities 25
BioMarin Pharmaceutical Inc - Threats 26
BioMarin Pharmaceutical Inc - Key Competitors 27
Section 3 Company Financial Ratios 28
Financial Ratios - Capital Market Ratios 28
Financial Ratios - Annual Ratios 29
Performance Chart 31
Financial Performance 31
Financial Ratios - Interim Ratios 32
Financial Ratios - Ratio Charts 33
Section 4 Companys Lifesciences Financial Deals and Alliances 34
BioMarin Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 34
BioMarin Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 35
BioMarin Pharmaceutical Inc, Recent Deals Summary 36
Section 5 Companys Recent Developments 37
Feb 05, 2018: BioMarin Announces 20 Presentations at 14th Annual WORLDSymposium 2018 37
Dec 14, 2017: Gene therapy success could lead to cure for haemophilia 40
Dec 09, 2017: New Therapies Improve Outlook for Bleeding and Clotting Disorders 41
Oct 26, 2017: BioMarin Announces Third Quarter 2017 Financial Results 44
Oct 18, 2017: BioMarin Highlights Breadth of Innovative Development Pipeline at R&D Day on October 18th in New York 48
Oct 11, 2017: BioMarin to Highlight Breadth of Innovative Development Pipeline at R&D Day on October 18th in New York 50
Oct 03, 2017: BioMarin Appoints Robert J. Hombach, Former Baxalta CFO and COO, to Board of Directors 51
Aug 02, 2017: BioMarin Announces Second Quarter 2017 Financial Results 52
May 04, 2017: BioMarin Announces First Quarter 2017 Financial Results 54
Feb 23, 2017: BioMarin Announces Fourth Quarter and Full Year 2016 Financial Results 56
Section 6 Appendix 58
Methodology 58
Ratio Definitions 58
About GlobalData 62
Contact Us 62
Disclaimer 62

List Of Tables

List of Tables
BioMarin Pharmaceutical Inc, Key Facts 6
BioMarin Pharmaceutical Inc, Key Employees 7
BioMarin Pharmaceutical Inc, Key Employee Biographies 8
BioMarin Pharmaceutical Inc, Major Products and Services 9
BioMarin Pharmaceutical Inc, History 10
BioMarin Pharmaceutical Inc, Subsidiaries 17
BioMarin Pharmaceutical Inc, Joint Venture 18
BioMarin Pharmaceutical Inc, Key Competitors 27
BioMarin Pharmaceutical Inc, Ratios based on current share price 28
BioMarin Pharmaceutical Inc, Annual Ratios 29
BioMarin Pharmaceutical Inc, Annual Ratios (Cont...1) 30
BioMarin Pharmaceutical Inc, Interim Ratios 32
BioMarin Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 34
BioMarin Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 35
BioMarin Pharmaceutical Inc, Recent Deals Summary 36
Currency Codes 58
Capital Market Ratios 58
Equity Ratios 59
Profitability Ratios 59
Cost Ratios 60
Liquidity Ratios 60
Leverage Ratios 61
Efficiency Ratios 61

List Of Figures

List of Figures
BioMarin Pharmaceutical Inc, Performance Chart (2013 - 2017) 31
BioMarin Pharmaceutical Inc, Ratio Charts 33
BioMarin Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 34
BioMarin Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 35

BioMarin Pharmaceutical Inc (BMRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

View Report

BioMarin Pharmaceutical Inc (BioMarin) is a biopharmaceutical company which develops and commercializes innovative pharmaceuticals that treat serious diseases and medical conditions. The company offers products for the treatment of various

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports